Company profile

Feops NV

Feops NV has 2 AI-enabled medical devices on the FDA list. The first decision was on June 6, 2023 and the most recent on November 25, 2025 (FEops HEARTguide Simulation Application). Its most common review panel is Cardiovascular (1 device).

2AI devices
2023First decision
2025Latest decision
2Specialties

Timeline

  1. FEops HEARTguide Simulation Application · Cardiovascular · QQI
  2. FEops HEARTguideTM, FEops HEARTguideTM ALPACA · Radiology · QIH